References
M. H. Alderman. 1996. Blood Pressure J-Curve: Is It Cause or Effect? Current Opinion in Nephrology and Hypertension 5: 3 209 - 13 (PubMed)
K. M. Anderson, P. M. Odell, P. W. Wilson and W. B. Kannel. 1991. Cardiovascular Disease Risk Profiles American Heart Journal 121: 1, part 2 293 - 98 (PubMed)
L. J. Appel, T. J. Moore, E. Obarzanek, W. M. Vollmer, L. P. Svetkey, F. M. Sacks , et al. , et al.. 1997. A Clinical Trial of the Effects of Dietary Patterns on Blood Pressure: DASH Collaborative Research Group New England Journal of Medicine 336: 16 1117 - 24 (PubMed)
Asia Pacific Cohort Studies Collaboration. 1999. Determinants of Cardiovascular Disease in the Asia Pacific Region: Protocol for a Collaborative Overview of Cohort Studies CVD Prevention 2: 281 - 89
———.2003a. Blood Pressure and Cardiovascular Disease in the Asia Pacific Region Journal of Hypertension 21: 707 - 16 (PubMed)
———.2003b. Cholesterol, Coronary Heart Disease, and Stroke in the Asia Pacific Region International Journal of Epidemiology 32: 563 - 72 (PubMed)
———.2004. Body Mass Index and Cardiovascular Disease in the Asia-Pacific Region: An Overview of 33 Cohorts Involving 305,000 Participants International Journal of Epidemiology 33: 1 - 8
G. Assmann, P. Cullen and H. Schulte. 2002. Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-up of the Prospective Cardiovascular Munster (PROCAM) Study Circulation 105: 310 - 15 (PubMed)
Blood Pressure Lowering Treatment Trialists' Collaboration. 2003. Effects of Different Blood-Pressure-Lowering Regimens on Major Cardiovascular Events: Results of Prospectively Designed Overviews of Randomised Trials: Blood Pressure Lowering Treatment Trialists' Collaboration Lancet 362: 9395 1527 - 35 (PubMed)
M. Bobak, Z. Skodova, Z. Pisa, R. Poledne and M. Marmot. 1997. Political Changes and Trends in Cardiovascular Risk Factors in the Czech Republic, 1985-92 Journal of Epidemiology and Community Health 51: 3 272 - 77 (PubMed)
E. E. Calle, M. J. Thun, J. M. Pettrelli, C. Rodriguez and C. Heath. 1999. Body Mass Index and Mortality in a Prospective Cohort of U.S. Adults New England Journal of Medicine 341: 15 1097 - 1105 (PubMed)
J. Caro, W. Klittich, A. McGuire, I. Ford, J. Norrie and D. Pettitt. 1997. The West of Scotland Coronary Prevention Study: Economic Benefit Analysis of Primary Prevention with Pravastatin British Medical Journal 315: 1577 - 82 (PubMed)
A. V. Chobanian, G. L. Bakris, H. R. Black, W. C. Cushman, L. A. Green, I. L. Izzo , et al. , et al.. 2003. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report Journal of the American College of Cardiology 289: 19 2560 - 72
A. J. Clegg, J. Colquitt, M. K. Sidhu, P. Royle, E. Loveman and A. Walker. 2002. The Clinical Effectiveness and Cost-Effectiveness of Surgery for People with Morbid Obesity: A Systematic Review and Economic Evaluation Health Technology Assessment (Winchester, U.K.) 6: 12 1 - 153
J. Connor, N. Rafter and A. Rodgers. 2004. Do Fixed-Dose Combination Pills or Unit-of-Use Packaging Improve Adherence? A Systematic Review Bulletin of World Health Organization 82: 935 - 39
J. M. Cruickshank. 1994. J-Curve in Antihypertensive Therapy: Does It Exist? A Personal Point of View Cardiovascular Drugs and Therapy 8: 5 757 - 60 (PubMed)
R. B. D'Agostino, A. J. Belanger, W. B. Kannel and J. M. Cruickshank. 1991. Relation of Low Diastolic Blood Pressure to Coronary Heart Disease Death in Presence of Myocardial Infarction: The Framingham Study British Medical Journal 303: 6799 385 - 89 (PubMed)
J. R. Downs, M. Clearfield, S. Weis, E. Whitney, D. R. Shapiro, P. A. Beere , et al. , et al.. 1998. Primary Prevention of Acute Coronary Events with Lovastatin in Men and Women with Average Cholesterol Levels: Results of AFCAPS/TexCAPS—Air Force/Texas Coronary Atherosclerosis Prevention Study Journal of the American Medical Association 279: 20 1615 - 22 (PubMed)
Ebrahim, S. 1998. "Detection, Adherence, and Control of Hypertension for the Prevention of Stroke: A Systematic Review." Health Technology Assessment (Winchester, U.K.) 2 (11): i-iv, 1-78.
A. Evans, H. Tolonen, H. W. Hense, M. Ferrario, S. Sans, K. Kuulasmaa , et al. , et al.. 2001. Trends in Coronary Risk Factors in the WHO MONICA Project International Journal of Epidemiology 30: Suppl. 1 S35 - 40 (PubMed)
Ezzati, M., A. Lopez, A. Rodgers, S. Vander Hoorn, and C. J. L. Murray, eds. 2004. Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors. Geneva: World Health Organization.
M. Ezzati, S. Hoorn, A. Rodgers, A. D. Lopez, C. D. Mathers, C. J. L. Murray , et al. , et al.. 2003. Estimates of Global and Regional Potential Health Gains from Reducing Multiple Major Risk Factors Lancet 362: 271 - 80 (PubMed)
L. Farnett, C. D. Mulrow, W. D. Linn, C. R. Lucey and M. R. Tuley. 1991. The J-Curve Phenomenon and the Treatment of Hypertension. Is There a Point Beyond Which Pressure Reduction Is Dangerous? Journal of the American Medical Association 265: 4 489 - 95 (PubMed)
M. Feinleib. 1996. New Directions for Community Intervention Studies American Journal of Public Health 86: 12 696 - 98 (PubMed)
A. E. Field, E. H. Coakley, A. Must, J. L. Spadano, N. Laird, W. H. Dietz , et al. , et al.. 2001. Impact of Overweight on the Risk of Developing Common Chronic Diseases during a 10-Year Period Archives of Internal Medicine 161: 1581 - 86 (PubMed)
J. M. Flack, J. Neaton, R. Grimm, J. Shih, J. Cutler, K. Ensrud , et al. , et al.. 1995. Blood Pressure and Mortality among Men with Prior Myocardial Infarction: Multiple Risk Factor Intervention Trial Research Group Circulation 92: 9 2437 - 45 (PubMed)
K. M. Fox and EUROPA (European Trial on Reduction of Cardiac Events with Perindopril in Stable Coronary Artery Disease) Investigators. 2003. Efficacy of Perindopril in Reduction of Cardiovascular Events among Patients with Stable Coronary Artery Disease: Randomised, Double-Blind, Placebo-Controlled, Multicentre Trial (the EUROPA Study) Lancet 362: 9386 782 - 88 (PubMed)
Gaziano, T. A., K. Steyn, D. J. Cohen, M. C. Weinstein, and L. H. Opie. 2005. Cost-effectiveness Analysis of Hypertension Guidelines in South Africa: Absolute Risk versus Blood Pressure Level.
L. Goldman, P.A. Weinstein and L.W. Williams. 1991. Cost-Effectiveness of HMG-CoA Reductase Inhibition for Primary and Secondary Prevention of Coronary Heart Disease JAMA 265: 1145 - 51 (PubMed)
P. Greenland, J. C. Levenkron, M. G. Radley, J. G. Baggs, R. A. Manchester and N. L. Bowley. 1987. Feasibility of Large-Scale Cholesterol Screening: Experience with a Portable Capillary-Blood Testing Device American Journal of Public Health 77: 73 - 75 (PubMed)
L. Hansson, L. H. Lindholm, T. Ekbom, B. Dahlof, J. Lanke, B. Schersten , et al. , et al.. 1999. Randomised Trial of Old and New Antihypertensive Drugs in Elderly Patients: Cardiovascular Mortality and Morbidity—The Swedish Trial in Old Patients with Hypertension-2 Study Lancet 354: 9192 1751 - 56 (PubMed)
I. U. Haq, L. E. Ramsay, W. W. Yeo, P. R. Jackson and E. J. Wallis. 1999. Is the Framingham Risk Function Valid for Northern European Populations? A Comparison of Methods for Estimating Absolute Coronary Risk in High Risk Men Heart 81: 1 40 - 46 (PubMed)
Harvey, E. L., A. M. Glenny, S. F. L. Kirk, and C. D. Summerbell. 2003. "Improving Health Professionals' Management and the Organisation of Care for Overweight and Obese People." Cochrane Database of Systematic Reviews (1).
J. W. Hay, W. M. Yu and T. Ashraf. 1999. Pharmacoeconomics of Lipid-Lowering Agents for Primary and Secondary Prevention of Coronary Artery Disease Pharmacoeconomics 15: 47 - 74 (PubMed)
Haynes, R. B., H. McDonald, A. X. Garg, and P. Montague. 2003. "Interventions for Helping Patients to Follow Prescriptions for Medications." Cochrane Database of Systematic Reviews (1).
J. He, M. J. Klag, P. K. Whelton, J. Y. Chen, J. P. Mo, M. C. Qian , et al. , et al.. 1991. Migration, Blood Pressure Pattern, and Hypertension: The Yi Migrant Study American Journal of Epidemiology 134: 10 1085 - 1101 (PubMed)
J. He, G. S. Tell, Y. C. Tang, P. S. Mo and G. Q. He. 1991. Effect of Migration on Blood Pressure: The Yi People Study Epidemiology 2: 2 88 - 97 (PubMed)
Heart Protection Study Collaborative Group. 2002. MRC/BHF Heart Protection Study of Cholesterol Lowering with Simvastatin in 20,536 High-Risk Individuals: A Randomised Placebo-Controlled Trial Lancet 360: 9326 7 - 22 (PubMed)
T. A. Hodgson and L. Cai. 2001. Medical Care Expenditures for Hypertension, Its Complications, and Its Comorbidities Medical Care 39: 599 - 615 (PubMed)
H. Iso, D. R. Jacobs, D. Wentworth, J. D. Neaton and J. D. Cohen. 1989. Serum Cholesterol Levels and Six-Year Mortality from Stroke in 350,977 Men Screened for the Multiple Risk Factor Intervention Trial New England Journal of Medicine 320: 14 904 - 10 (PubMed)
R. Jackson, P. Barham, J. Bills, T. Birch, L. McLennan, S. MacMahon , et al. , et al.. 1993. Management of Raised Blood Pressure in New Zealand: A Discussion Document British Medical Journal 307: 107 - 10 (PubMed)
M. Johannesson, L. Borgquist, B. Jonsson and L. Rastam. 1991. The Costs of Treating Hypertension: An Analysis of Different Cutoff Points Health Policy 18: 2 141 - 50 (PubMed)
J. G. Joseph, I. A. Prior, C. E. Salmond and D. Stanley. 1983. Elevation of Systolic and Diastolic Blood Pressure Associated with Migration: The Tokelau Island Migrant Study Journal of Chronic Diseases 36: 7 507 - 16 (PubMed)
W. B. Kannel, R. B. D'Agostino and H. Silbershatz. 1997. Blood Pressure and Cardiovascular Morbidity and Mortality Rates in the Elderly American Heart Journal 134: 4 758 - 63 (PubMed)
N. M. Kaplan. 1995. Alcohol and Hypertension Lancet 345: 8965 1588 - 89 (PubMed)
J. Kupersmith, M. Holmes-Rovner, A. Hogan, D. Rovner and J. Gardiner. 1995. Cost-Effectiveness Analysis in Heart Disease, Part II: Preventive Therapies Progress in Cardiovascular Diseases 37: 243 - 71 (PubMed)
M. Law. 2000. Plant Sterol and Stanol Margarines and Health British Medical Journal 320: 861 - 64 (PubMed)
M. Law, C. Frost and N. Wald. 1991. By How Much Does Dietary Salt Reduction Lower Blood Pressure? III: Analysis of Data from Trials of Salt Reduction British Medical Journal 302: 819 - 24 (PubMed)
M. R. Law, N. J. Wald, J. K. Morris and R. E. Jordan. 2003. Value of Low Dose Combination Treatment with Blood Pressure Lowering Drugs: Analysis of 354 Randomised Trials British Medical Journal 326: 7404 1427 (PubMed)
M. R. Law, N. J. Wald and A. R. Rudnicka. 2003. Quantifying Effect of Statins on Low Density Lipoprotein Cholesterol, Ischaemic Heart Disease, and Stroke: Systematic Review and Meta-Analysis British Medical Journal 326: 7404 1423 (PubMed)
M. R. Law, N. J. Wald and S. G. Thompson. 1994. By How Much and How Quickly Does Reduction in Serum Cholesterol Concentration Lower Risk of Ischaemic Heart Disease? British Medical Journal 308: 6925 367 - 72 (PubMed)
M. R. Law, H. C. Watt and N. J. Wald. 2002. The Underlying Risk of Death after Myocardial Infarction in the Absence of Treatment Archives of Internal Medicine 162: 21 2405 - 10 (PubMed)
C. M. M. Lawes, D. A. Bennett, V. L. Feigin and A. Rodgers. 2004. Blood Pressure and Stroke: An Overview of Published Reviews Stroke 35: 776 - 85 (PubMed)
Leeder, S., S. Raymond, H. Greenburg, H. Liu, and K. Esson. 2004. A Race against Time: The Challenge of Cardiovascular Disease in Developing Economies. New York: Columbia University.
S. MacMahon, A. Rodgers, B. Neal and J. Chalmers. 1997. Blood Pressure Lowering for the Secondary Prevention of Myocardial Infarction and Stroke Hypertension 29: 537 - 38 (PubMed)
Management Sciences for Health. 2004. International Drug Price Indicator Guide. Washington, DC: Management Sciences for Health.
J. E. Manson, W. C. Willett and M. J. Stampfer. 1995. Body Weight and Mortality among Women New England Journal of Medicine 333: 11 677 - 85 (PubMed)
J. McMurray and G. T. McInnes. 1992. The J-Curve Hypothesis Lancet 339: 8792 561 - 62
M. B. Mittelmark, M. K. Hunt, G. W. Heath and T. L. Schmid. 1993. Realistic Outcomes: Lessons from Community-Based Research and Demonstration Programs for the Prevention of Cardiovascular Diseases Journal of Public Health Policy 14: 4 437 - 62 (PubMed)
C. A. Monteiro, W. L. Conde, B. Lu and B. M. Popkin. 2004. Obesity and Inequities in Health in the Developing World International Journal of Obesity 28: 1181 - 86 (PubMed)
C. J. L. Murray, J. A. Lauer, R. C. W. Hutubessy, L. Niessen, N. Tomijima, A. Rodgers , et al. , et al.. 2003. Reducing the Risk of Cardiovascular Disease: Effectiveness and Costs of Interventions to Reduce Systolic Blood Pressure and Cholesterol: A Global and Regional Analysis Lancet 361: 717 - 25 (PubMed)
Murray, L., ed. 2004. Red Book. Montvale, NJ: Thomson Physicians Desk Reference.
NCEP (National Cholesterol Education Program) Expert Panel. 2002. Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute.
J. D. Neaton and D. Wentworth. 1992. Serum Cholesterol, Blood Pressure, Cigarette Smoking, and Death from Coronary Heart Disease: Overall Findings and Differences by Age for 316,099 White Men—Multiple Risk Factor Intervention Trial Research Group Archives of Internal Medicine 152: 1 56 - 64 (PubMed)
NHLBI (National Heart, Lung, and Blood Institute) Obesity Education Initiative Expert Panel 1998. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Bethesda, MD: National Institutes of Health, NHLBI.
A. Nissinen, X. Berrios and P. Puska. 2001. Community-Based Noncommunicable Disease Interventions: Lessons from Developed Countries for Developing Ones Bulletin of the World Health Organization 79: 10 963 - 70 (PubMed)
S. O'Meara, R. Riemsma, L. Shirran, L. Mather and G. ter Riet. 2001. A Rapid and Systematic Review of the Clinical Effectiveness and Cost-Effectiveness of Orlistat in the Management of Obesity Health Technology Assessment (Winchester, U.K.) 5: 18 1 - 81
———.2002. The Clinical Effectiveness and Cost-Effectiveness of Sibutramine in the Management of Obesity: A Technology Assessment Health Technology Assessment (Winchester, U.K.) 6: 6 1 - 97
C. J. Pepine, E. M. Handberg, R. M. Cooper-DeHoff, R. G. Marks, P. Kowey, F. H. Messerli , et al. , et al.. 2003. A Calcium Antagonist vs. a Non-Calcium Antagonist Hypertension Treatment Strategy for Patients with Coronary Artery Disease—The International Verapamil-Trandolapril Study (INVEST): A Randomized Controlled Trial Journal of the American Medical Association 290: 21 2805 - 16 (PubMed)
J. A. Pestana, K. Steyn, A. Leiman and G. M. Hartzenberg. 1996. The Direct and Indirect Costs of Cardiovascular Disease in South Africa in 1991 South African Medical Journal 86: 6 679 - 84 (PubMed)
M. A. Pfeffer. 1993. Angiotensin-Converting Enzyme Inhibition in Congestive Heart Failure: Benefit and Perspective American Heart Journal 126: 3, part 2 789 - 93 (PubMed)
N. R. Poulter. 1999. Coronary Heart Disease Is a Multifactorial Disease American Journal of Hypertension 12: 10, part 2 92 - 95S
N. R. Poulter, K. T. Khaw and P. S. Sever. 1988. Higher Blood Pressures of Urban Migrants from an African Low-Blood Pressure Population Are Not Due to Selective Migration American Journal of Hypertension 1: 3 Pt. 3 143S - 45S (PubMed)
Poulter, N. R., and P. Sever. 1994. "Blood Pressure in Other Populations: A. Low Blood Pressure Populations and the Impact of Rural-Urban Migration." In Textbook of Hypertension, ed. J. Swales, 22-36. Oxford, U.K.: Blackwell Scientific Publications.
Progress Collaborative Group. 2001. Randomised Trial of a Perindopril-Based Blood-Pressure-Lowering Regimen among 6,105 Individuals with Previous Stroke or Transient Ischaemic Attack Lancet 358: 9287 1033 - 41 (PubMed)
Prospective Studies Collaboration. 1995. Cholesterol, Diastolic Blood Pressure, and Stroke: 13,000 Strokes in 45,000 People in 45 Prospective Cohorts Lancet 346: 1647 - 53 (PubMed)
———.2002. Age-Specific Relevance of Usual Blood Pressure to Vascular Mortality: A Meta-Analysis of Individual Data for One Million Adults in 61 Prospective Studies Lancet 360: 1903 - 13 (PubMed)
L. A. Prosser, A. A. Stinnett, P. A. Goldman, L. W. Williams, M. G. Hunink and L. Goldman. 2000. Cost-Effectiveness of Cholesterol-Lowering Therapies According to Selected Patient Characteristics Annals of Internal Medicine 132: 769 - 79 (PubMed)
P. Puska. 1999. The North Karelia Project: From Community Intervention to National Activity in Lowering Cholesterol Levels and CHD Risk European Heart Journal 1: Suppl. S9 - 13
L. E. Ramsay, B. Williams, G. D. Johnston, G. A. MacGregor, L. Poston, J. F. Potter , et al. , et al.. 1999. British Hypertension Society Guidelines for Hypertension Management 1999: Summary British Medical Journal 319: 7210 630 - 35 (PubMed)
G. Rose. 1981. Strategy of Prevention: Lessons from Cardiovascular Disease British Medical Journal 282: 1847 - 51 (PubMed)
———.1985. Sick Individuals and Sick Populations International Journal of Epidemiology 14: 32 - 38 (PubMed)
C. E. Salmond, J. G. Joseph, I. A. Prior, D. G. Stanley and A. F. Wessen. 1985. Longitudinal Analysis of the Relationship between Blood Pressure and Migration: The Tokelau Island Migrant Study American Journal of Epidemiology 122: 2 291 - 301 (PubMed)
C. E. Salmond, I. A. Prior and A. F. Wessen. 1989. Blood Pressure Patterns and Migration: A 14-Year Cohort Study of Adult Tokelauans American Journal of Epidemiology 130: 1 37 - 52 (PubMed)
C. Schooler, J. W. Farquhar, S. P. Fortmann and J. A. Flora. 1997. Synthesis of Findings and Issues from Community Prevention Trials Annals of Epidemiology 7: Suppl. S54 - 68
M. Serdula, A. Mokad, D. Williamson, D. Galuska, J. Mendlein and G. Heath. 1999. Prevalence of Attempting Weight Loss and Strategies for Controlling Weight Journal of the American Medical Association 282: 14 1353 - 58 (PubMed)
P. Sleight. 1997a. Lowering of Blood Pressure and Artery Stiffness Lancet 349: 9048 362
———.1997b. Lowering of Blood Pressure and Artery Stiffness Lancet 349: 9056 955 - 56 (PubMed)
J. Staessen, R. Fagard, L. Thijs, H. Celis, G. Arabidze, W. Birkenhager , et al. , et al.. 1997. Randomised Double-Blind Comparison of Placebo and Active Treatment for Older Patients with Isolated Systolic Hypertension Lancet 350: 757 - 64 (PubMed)
J. Stevens, J. Cai, E. R. Pamuk, D. F. Williamson, M. J. Thun and J. L. Wood. 1998. The Effect of Age on the Association between Body-Mass Index and Mortality New England Journal of Medicine 338: 1 1 - 7 (PubMed)
I. M. Stewart. 1979. Relation of Reduction in Pressure to First Myocardial Infarction in Patients Receiving Treatment for Severe Hypertension Lancet 1: 8121 861 - 65 (PubMed)
I. Suh. 2001. Cardiovascular Mortality in Korea: A Country Experiencing Epidemiologic Transition Acta Cardiologica 56: 2 75 - 81 (PubMed)
M. Susser. 1995. The Tribulations of Trials—Intervention in Communities American Journal of Public Health 85: 2 156 - 58 (PubMed)
B. Swinburn, T. Ashton, J. Gillespie, B. Cox, A. Menon, D. Simmons , et al. , et al.. 1997. Health Care Costs of Obesity in New Zealand International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 21: 891 - 96 (PubMed)
A. N. A. Tosteson, M. C. Weinstein, M. G. M. Hunink, M. A. Mittleman, L. W. Williams, P. A. Goldman , et al. , et al.. 1997. Cost-Effectiveness of Populationwide Educational Approaches to Reduce Serum Cholesterol Levels Circulation 95: 24 - 30 (PubMed)
R. P. Troiano, E. A. Frongillo, J. Sobal and D. A. Levitsky. 1996. The Relationship between Body Weight and Mortality: A Quantitative Analysis of Combined Information from Existing Studies International Journal of Obesity and Related Metabolic Disorders 20: 63 - 75 (PubMed)
U. Uusitalo, E. J. Feskens, J. Tuomilehto, G. Dowse, U. Haw, D. Fareed , et al. , et al.. 1996. Fall in Total Cholesterol Concentration over Five Years in Association with Changes in Fatty Acid Composition of Cooking Oil in Mauritius: Cross-Sectional Survey British Medical Journal 313: 7064 1044 - 46 (PubMed)
N. J. Wald and M. R. Law. 2003. A Strategy to Reduce Cardiovascular Disease by More Than 80 Percent British Medical Journal 326: 7404 1419 (PubMed)
G. Wang, Z. J. Zheng, G. Heath, C. Macera, M. Pratt and D. Buchner. 2002. Economic Burden of Cardiovascular Disease Associated with Excess Body Weight in U.S. Adults American Journal of Preventive Medicine 23: 1 - 6
L. Y. Wang, Q. Yang, R. Lowry and H. Wechsler. 2003. Economic Analysis of a School-Based Obesity Prevention Program Obesity Research 11: 1313 - 24 (PubMed)
P. K. Whelton, L. J. Appel, M. A. Espeland, W. B. Applegate, W. H. Ettinger, J. B. Kostis , et al. , et al.. 1998. Sodium Reduction and Weight Loss in the Treatment of Hypertension in Older Persons: A Randomized Controlled Trial of Nonpharmacologic Interventions in the Elderly (TONE): TONE Collaborative Research Group Journal of the American Medical Association 279: 11 839 - 46 (PubMed)
WHO (World Health Organization). 2001. Macroeconomics and Health: Investing in Health for Economic Development—Report of the Commission on Macroeconomics and Health. Geneva: WHO. http://www.cmhealth.org/.
———. 2002. World Health Report 2002: Reducing Risks, Promoting Healthy Life. Geneva: WHO.
———. 2003a. Adherence to Long-Term Therapies: Evidence for Action. Geneva: WHO.
———. 2003b. Diet, Nutrition, and the Prevention of Chronic Diseases. Geneva: WHO.
W. C. Willett, J. E. Manson, M. J. Stampfer, G. A. Colditz, B. Rosner, F. E. Speizer , et al. , et al.. 1995. Weight, Weight Change, and Coronary Heart Disease in Women: Risk within the `Normal' Weight Range Journal of the American Medical Association 273: 6 461 - 65 (PubMed)
D. Wood, G. De Backer, O. Faergeman, I. Graham, G. Mancia, K. Pyorala , et al. , et al.. 1998. Prevention of Coronary Heart Disease in Clinical Practice: Summary of Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention Journal of Hypertension 16: 1404 - 14
X. Wu, Z. Huang, J. Stamler, Y. Wu, Y. Li, A. R. Folsom , et al. , et al.. 1996. Changes in Average Blood Pressure and Incidence of High Blood Pressure 1983-1984 to 1987-1988 in Four Population Cohorts in the People's Republic of China: The PRC-USA Cardiovascular and Cardiopulmonary Epidemiology Research Group Journal of Hypertension 14: 11 1267 - 74 (PubMed)
Xact Medicare Services. 2003. Medicare Clinical Laboratory Fee Schedule. Camp Hill, PA: Xact Medicare Services.
S. Yusuf. 2002. Two Decades of Progress in Preventing Vascular Disease Lancet 360: 9326 2 - 3 (PubMed)
